CWM
AUPH icon

CIBC World Markets’s Aurinia Pharmaceuticals AUPH Stock Holding History

CIBC World Markets’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$123K Sell
14,513
-15,276
-51% -$122K ﹤0.01% 1374
2025
Q1 		$240K Buy
29,789
+17,226
+137% +$140K ﹤0.01% 1370
2024
Q4 		$113K Buy
+12,563
New +$103K ﹤0.01% 1202

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CIBC World Markets's AUPH Position: Q2 2025 in Review

CIBC World Markets reduced its Aurinia Pharmaceuticals (AUPH) stake by 51% in Q2 2025, selling an estimated $122K and leaving 14,513 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #1374.

CIBC World Markets first reported a position in AUPH in Q4 2024 and has held it in 3 quarters since. The position peaked at $240K in Q1 2025. 219 funds tracked by Wall St. Rank hold AUPH as of Q2 2025.

  • CIBC World Markets held 14,513 shares of Aurinia Pharmaceuticals worth $123K as of Q2 2025.
  • CIBC World Markets sold 15,276 Aurinia Pharmaceuticals shares in Q2 2025, an estimated $122K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1374 holding.
  • CIBC World Markets first reported a position in Aurinia Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • CIBC World Markets's Aurinia Pharmaceuticals position peaked at $240K in Q1 2025.
  • 219 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.